Shubham Pant, Professor of Gastrointestinal Medical Oncology and Investigational Cancer Therapeutics at MD Anderson Cancer Center, shared on LinkedIn:
“Looking forward to joining Upper GI and HPB Updates 2026 virtually to deliver the keynote address.
Metastatic Pancreatic Cancer 2026: From Cytotoxicity to KRAS: Are We Finally Changing the Game?
Time: Saturday, October 31 | 6:45–7:05 PM IST
Location: ITC Windsor, Bengaluru (joining remotely)
For decades, cytotoxic chemotherapy has been the backbone of treatment for metastatic pancreatic cancer, with modest gains. KRAS, mutated in more than 90% of these tumors, was long considered ‘undruggable.’
That is now changing. I’ll walk through where the field stands today, including the latest data presented ESMO – European Society for Medical Oncology.
Thank you to Dr. Vishwanath Sathyanarayanan Apollo Cancer Centres for the invitation.”
Other articles featuring Shubham Pant on OncoDaily.